New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Allurion Technologies, Inc. (ALUR) vs CVRx, Inc. (CVRX)

Allurion Technologies, Inc. and CVRx, Inc. are both Medical Devices companies. Allurion Technologies, Inc. and CVRx, Inc. are of similar size ($17.2M and $16.7M). CVRx, Inc. grew revenue faster over the last twelve months: 7.79% against −55.5%. CVRx, Inc. has the higher net margin (−88.3% vs −264.7%) and the lower return on invested capital (−225.0% vs 0.00%). Across the 15 metrics below, CVRx, Inc. leads on 9 and Allurion Technologies, Inc. on 6.

Valuation

Metric ALUR CVRX Medical Devices median
P/E n/m n/m 22.36
P/S n/m 0.24 2.40
P/B n/m 1.05 2.34
Price to free cash flow n/m n/m 26.16
EV/EBITDA n/m n/m 10.97
EV/Sales 5.25 0.29 2.37
Earnings yield 0.00% (379.25%) (11.89%)
Free cash flow yield 0.00% (291.15%) (9.71%)

Profitability

Metric ALUR CVRX Medical Devices median
Gross margin 52.70% 86.90% 58.08%
Operating margin (211.21%) (81.90%) (17.17%)
Net margin (264.74%) (88.28%) (16.35%)
Free cash flow margin (180.19%) (69.69%) (6.21%)
Return on equity 45.16% (172.17%) (21.47%)
Return on assets (127.26%) (53.55%) (17.83%)
Return on invested capital 0.00% (224.98%) (8.54%)

Growth

Metric ALUR CVRX Medical Devices median
Revenue growth (TTM) (55.49%) 7.79% 10.47%
EPS growth (last fiscal year) (18.97%) 23.02% 28.60%
Revenue growth, 5-year CAGR — 56.40% 15.88%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALUR CVRX Medical Devices median
Debt to equity 0.00 4.24 0.05
Current ratio 0.30 6.80 2.81
Net debt to EBITDA 0.19 0.52 0.53

Dividend

Metric ALUR CVRX Medical Devices median
Dividend yield — — 1.04%
Payout ratio — — 0.37

Size

Metric ALUR CVRX Medical Devices median
Market cap 16.70m 17.20m 200.67m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack